Banque Cantonale Vaudoise Sangamo Therapeutics, Inc Transaction History

Banque Cantonale Vaudoise

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $265,676 - $399,790	-36,444 Reduced 99.75%	93 $1,000
Q3 2021 Oct 29, 2021	SELL	$9.01 - $12.01 $24,444 - $32,583	-2,713 Reduced 6.91%	36,537 $329,000
Q2 2021 Aug 11, 2021	SELL	$10.17 - $12.64 $14,685 - $18,252	-1,444 Reduced 3.55%	39,250 $470,000
Q1 2021 May 11, 2021	SELL	$10.88 - $17.05 $90,793 - $142,282	-8,345 Reduced 17.02%	40,694 $510,000
Q4 2020 Feb 05, 2021	BUY	$9.23 - $18.18 $240,792 - $474,279	26,088 Added 113.67%	49,039 $765,000
Q3 2020 Oct 30, 2020	BUY	$9.38 - $12.48 $2,654 - $3,531	283 Added 1.25%	22,951 $216,000
Q2 2020 Jul 22, 2020	BUY	$6.21 - $11.83 $13,525 - $25,765	2,178 Added 10.63%	22,668 $203,000
Q1 2020 May 14, 2020	SELL	$5.05 - $8.85 $10,019 - $17,558	-1,984 Reduced 8.83%	20,490 $131,000
Q4 2019 Feb 10, 2020	BUY	$8.03 - $11.7 $180,466 - $262,945	22,474 New	22,474 $188,000

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.